Category

Clinical Trials

jakob_lindberg_oncopeptides

New data from Oncopeptides

March 4, 2019

Data from the company’s Phase …

Affibody

Affibody completes enrollment of Phase II trial

February 26, 2019

The biopharmaceutical company announces the …

José Baselga

Phase III results from AstraZeneca

February 26, 2019

AstraZeneca and MSD have announced …

STAR Investigators meeting

Sigrid Therapeutics initiates clinical trial

February 25, 2019

The Swedish clinical-stage biotech company …

Bavarian Nordic Research

Bavarian Nordic initiates Phase I/IIa trial

February 25, 2019

The first patient has been …

Elisabeth Bjork

New results from AstraZeneca’s Brilinta trial

February 25, 2019

The Phase III THEMIS trial …

Spago Nanomedical Research

Spago Nanomedical initiates clinical trial

February 20, 2019

The company has received approval …

Christer Nordstedt

Positive results from Orion trial

February 18, 2019

Orion’s and Bayer’s darolutamide shows …

Lundbeck Research

Phase III data from Lundbeck did not meet the primary endpoint

February 14, 2019

Lundbeck and Otsuka report new …

Cancer cells

First patient treated in Immunicum trial

February 11, 2019

The first patient has been …

laboratory

Orion and Bayer present new data from the Darolutamide ARAMIS -study

February 6, 2019

First presentation of data from …

LIDDS Research

LIDDS adds new clinic to their clinical trial

February 6, 2019

The company has received approval …

Magnus Doverskog

Umecrine Cognition announces results from a Phase 2a study

February 3, 2019

The Umeå-based company reports new …

cantargia

First patient treated in Cantargia trial

January 28, 2019

The first patient in the …

John Öhd

Modus Therapeutics completes enrollment of Phase II study

January 7, 2019

The company announces that it …

lundbeck-research

Lundbeck initiates new Phase II study

January 4, 2019

The company initiates a phase …

1
2
3
4
···
23